Azelis stock faces Jefferies downgrade as growth meets leverage

Jefferies downgraded Azelis to Hold from Buy on Wednesday, November 11, 2026, and cut its price target to 13 euros from 15 euros. The brokerage said a recovery toward moderate, volume-driven growth and improving margins was already reflected in the shares after their strong advance. The assessment was reported by Investing.com.

Broker Sees Slower Recovery

Analyst David Kerstens raised the assumed cost of capital for Azelis to 10 percent from 9 percent and applied stricter return criteria. Jefferies expects the specialty-distribution sector to benefit from gradually normalising industry conditions, but said the fading inflation tailwind means investors are waiting for clearer volume growth.

The downgrade comes against a stronger underlying third quarter. Azelis reported revenue growth of 8.2 percent on an organic basis, while earnings before interest, taxes and amortization rose 15 percent to 114 million euros. The gross margin held at 23.4 percent, indicating that the operating recovery was accompanied by stable profitability at the reported level.

Cash Conversion Remains Critical

Cash generation remains the main counterweight to the operating improvement. Free cash flow fell 52 percent to 67 million euros as the group invested more working capital, including inventory to support recovering demand. Leverage stood at 3.5 times EBITDA, above the company target of below 3 times.

Azelis also recorded a 350 million euro non-cash goodwill impairment related mainly to past acquisitions in the Americas. The charge weighed on reported earnings and equity but did not directly affect cash flow, working capital or net debt. For investors, the combination of better organic growth and weaker cash conversion makes execution on working capital and debt reduction important to any potential valuation recovery.

Management Keeps 2026 Target

Management continues to target positive organic adjusted EBITA growth for the full year 2026. Azelis also maintains medium-term ambitions for high-single-digit adjusted EBITA growth, earnings-per-share growth and a return on capital employed above 11.5 percent. Jefferies expects a 6 percent EBITA recovery and noted that Azelis does not expect to complete acquisitions this year while leverage and asking prices remain high.

Azelis stock traded at 11.88 euros on Lang & Schwarz at 10:40 CET on Thursday, November 12, 2026.

European market developments provide the wider context for Azelis investors through Current market reports.

Investors will focus next on fourth-quarter working-capital normalisation, further EBITA progress and the path toward lower leverage. More news and analyses on Azelis stock.